“…Dfe treatment improved mitochondrial dysfunction through Kv2.1/CaMKKβ/AMPK/PGC-1α pathway : Given the pivotal role of AMPK/PGC-1α signaling in mitochondrial energy homeostasis ( Calcutt et al., 2017 ; Herzig et al., 2018 ; Hashem et al., 2017 ), we detected the potential of Dfe treatment in regulating AMPK/PGC-1α signaling in DRG tissue of DPN mice by western blot. The results demonstrated that the levels of phosphorylated AMPK and PGC-1α were decreased from DPN mice (STZ, db/db ) compared with those from control mice (Control, db /m) but increased from the Dfe-treated DPN mice (STZ + Dfe, db/db + Dfe) compared with the vehicle-treated DPN mice (STZ, db/db ) ( Figures 5 I–5L) (for p-AMPK, F (2, 6) = 91.83 in STZ mice, 56.34 in db/db mice; for PGC1-α, F (2, 6) = 79.92 in STZ mice, 20.91 in db/db mice; for AMPK, F (2, 6) = 3.235 in STZ mice, 1.179 in db/db mice; for p-ACC, F (2, 6) = 3.615 in STZ mice, 4.675 in db/db mice).…”